ST2: Marker, activator and regulator of Th2 immunity?

Clinical and Experimental Allergy

Volumn 32, Issue 10, 2002, Pages 1394-1396

  Kumar, R K ^a   Foster, P S ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Biology and Environment   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

EDITORIAL; IMMUNITY; MEDICAL LITERATURE; PRIORITY JOURNAL; REGULATORY MECHANISM; TH2 CELL;

ANIMALS; ASTHMA; GENE EXPRESSION; GENETIC MARKERS; HUMANS; MEMBRANE PROTEINS; MODELS, ANIMAL; RECEPTORS, CELL SURFACE; TH2 CELLS;

EID: 0036411758     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2745.2002.01517.x     Document Type: Editorial

References (38)

1. Robinson DS, Hamid Q, Ying S et al. Predominant TH2-1ike bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326:298-304.
2. Humbert M, Corrigan CJ, Kimmitt P, Till S J, Kay AB, Durham SR. Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma. Am J Respir Crit Care Med 1997; 156:704-8.
3. Kaminuma O, Mori A, Ogawa K et al. Successful transfer of late phase T cell eosinophil infiltration in the lung by infusion of helper T cell clones. Am J Respir Cell Mol Biol 1997; 16:448-54.
4. Hogan SP, Koskinen A, Matthaei KI, Young IG, Foster PS. Interleukin-5-producing CD4+ T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice. Am J Respir Crit Care Med 1998; 157:210-8.
5. Shi HZ, Xiao CQ, Zhong D et al. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics. Am J Respir Crit Care Med 1998; 157:204-9.
6. Yang M, Hogan SP, Henry PJ et al. Interleukin-13 mediates airways hyperreactivity through the IL-4 receptor-α chain and STAT-6 independently of IL-5 and eotaxin. Am J Respir Cell Mol Biol 2001; 25:522-30.
7. Venkayya R, Lam M, Willkom M, Grunig G, Corry DB, Erie DJ. The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am J Respir Cell Mol Biol 2002; 26:202-8.
8. Salvi SS, Babu KS, Holgate ST. Is asthma really due to a polarized T cell response toward a helper T cell type 2 phenotype? Am J Respir Crit Care Med 2001; 164:1343-6.
9. Krug N, Madden J, Redington AE et al. T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma. Am J Respir Cell Mol Biol 1996; 14:319-26.
10. Magnan AO, Mely LG, Camilla CA et al. Assessment of the Thl/ Th2 paradigm in whole blood in atopy and asthma: Increased IFNγ-producing CD8+ T cells in asthma. Am J Respir Crit Care Med 2000; 161:1790-6.
11. Bradding P, Roberts JA, Britten KM et al. Interleukin-4,-5, and -6 and tumor necrosis factor-α in normal and asthmatic airways: Evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994; 10:471-80.
12. Jaffe JS, Raible DB, Post YJ et al. Human lung mast cell activation leads to IL-13 mRNA expression and protein release. Am J Respir Cell Mol Biol 1996; 15:473-81.
13. Kobayashi H, Ishizuka T, Okayama Y. Human mast cells and basophils as sources of cytokines. Clin Exp Allergy 2000; 30:1205-12.
14. Hogan SP, Foster PS. Cytokines as targets for the inhibition of eosinophilic inflammation. Pharmacol Ther 1997; 74:259-83.
15. Borish LC, Nelson HS, Lanz MJ et al. Interleukin-4 receptor in moderate atopic asthma: A phase I/II randomized, placebo-controlled trial. Am J Respir Crit Care Med 1999; 160:1816-23.
16. Leckie M J, ten Brinke A, Khan J et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyperresponsiveness, and the late asthmatic response. Lancet 2000; 356:2144-8.
17. Gavett HH, Chen X, Finkelman F, Wills-Karp M. Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am J Respir Cell Mol Biol 1994; 10:587-93.
18. Foster PS, Yang M, Herbert C, Kumar RK. CD4+ T-lymphocytes regulate airway remodeling and hyper-reactivity in a mouse model of chronic asthma. Laboratory Invest 2002; 82:455-62.
19. Kon OM, Sihra BS, Compton CH, Leonard TB, Kay AB, Barnes NC. Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma. Lancet 1998; 352:1109-13.
20. Khan LN, Kon OM, Macfarlane AJ et al. Attenuation of the allergen-induced late asthmatic reaction by cyclosporin A is associated with inhibition of bronchial eosinophils, interleukin-5, granulocyte macrophage colony-stimulating factor, and eotaxin. Am J Respir Crit Care Med 2000; 162:1377-82.
21. Tournoy KG, Kips JC, Pauwels RA. Is Th1 the solution for Th2 in asthma? Clin Exp Allergy 2002; 32:17-29.
22. Randolph DA, Carruthers CJL, Szabo S J, Murphy KM, Chaplin DD. Modulation of airway inflammation by passive transfer of allergen-specific Th1 and Th2 cells in a mouse model of asthma. J Immunol 1999; 162:2375-83.
23. Hansen G, Berry G, DeKruyff RH, Umetsu DT. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999; 103:175-83.
24. Mattes J, Yang M, Siqueira A et al. IL-13 induces airways hyperreactivity independently of the IL-4Rα chain in the allergic lung. J Immunol 2001; 167:1683-92.
25. Bergers G, Reikerstorfer A, Braselmann S, Graninger P, Busslinger M. Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J 1994; 13:1176-88.
26. Tominaga S. A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor. FEBS Lett 1989; 258:3014.
27. Moritz DR, Rodewald HR, Gheyselinck J, Klemenz R. The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors. J Immunol 1998; 161:4866-74.
28. Xu D, Chan WL, Leung BP et al. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med 1998; 187:787-94.
29. Lohning M, Stroehmann A, Coyle AJ et al. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci USA 1998; 95:6930-5.
30. Gajewska BU, Swirski FK, Alvarez D et al. Temporal-spatial analysis of the immune response in a murine model of ovalbumin-induced airways inflammation. Am J Respir Cell Mol Biol 2001; 25:326-34.
31. Coyle AJ, Lloyd C, Tian J et al. Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J Exp Med 1999; 190:895-902.
32. Walzl G, Matthews S, Kendall S et al. Inhibition of T1/ST2 during respiratory syncytial virus infection prevents T helper cell type 2 (Th2) - But not Th1-driven immunopathology. J Exp Med 2001; 193:785-92.
33. Hoshino K, Kashiwamura S, Kuribayashi K et al. The absence of interleukin 1 receptor-related T1/ST2 does not affect T helper cell type 2 development and its effector function. J Exp Med 1999; 190:1541-8.
34. Townsend M J, Fallon PG, Matthews D J, Jolin HE, McKenzie AN. T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J Exp Med 2000; 191:1069-76.
35. Senn KA, McCoy KD, Maloy KJ et al. T1-deficient and T1-Fc-transgenic mice develop a normal protective Th2-type immune response following infection with Nippostrongylus brasiliensis. Eur J Immunol 2000; 30:1929-38.
36. Lambrecht BN, De Veerman M, Coyle AJ, Gutierrez-Ramos JC, Thielemans K, Pauwels RA. Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J Clin Invest 2000; 106:551-9.
37. shikawa K, Kuroiwa K, Tago K et al. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med 2001; 164:277-81.
38. Oshikawa K, Yanagisawa K, Tominaga S, Sugiyama Y. Expression and function of ST2 gene in a murine model of allergic airway inflammation. Clin Exp Allergy 2002; 32:1520-6.